Advanced RA Therapies

Cross-source consensus on Advanced RA Therapies from 1 sources and 3 claims.

1 sources · 3 claims

Comparisons

Of 958 registry patients who received advanced RA treatment, 637 entered the final analytic cohort with CDAI scores at baseline and one year. — Associations between achieving treatment targets and functional and economic outcomes in patients with rheumatoid arthritis: retrospective cohort analyses of BRASS registry data
The study's advanced-treatment population consisted of patients receiving biologics or JAK inhibitors. — Associations between achieving treatment targets and functional and economic outcomes in patients with rheumatoid arthritis: retrospective cohort analyses of BRASS registry data
Advanced-treatment use by drug class did not significantly differ across the four primary target groups at baseline, year 1, or year 2. — Associations between achieving treatment targets and functional and economic outcomes in patients with rheumatoid arthritis: retrospective cohort analyses of BRASS registry data